1-46819251-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001099772.2(CYP4B1):c.*437T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0376 in 159,584 control chromosomes in the GnomAD database, including 246 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association (no stars).
Frequency
Genomes: 𝑓 0.039 ( 242 hom., cov: 32)
Exomes 𝑓: 0.017 ( 4 hom. )
Consequence
CYP4B1
NM_001099772.2 3_prime_UTR
NM_001099772.2 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.622
Publications
7 publications found
Genes affected
CYP4B1 (HGNC:2644): (cytochrome P450 family 4 subfamily B member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. In rodents, the homologous protein has been shown to metabolize certain carcinogens; however, the specific function of the human protein has not been determined. Multiple transcript variants have been found for this gene. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0966 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0385 AC: 5864AN: 152196Hom.: 239 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
5864
AN:
152196
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0166 AC: 121AN: 7270Hom.: 4 Cov.: 0 AF XY: 0.0180 AC XY: 67AN XY: 3722 show subpopulations
GnomAD4 exome
AF:
AC:
121
AN:
7270
Hom.:
Cov.:
0
AF XY:
AC XY:
67
AN XY:
3722
show subpopulations
African (AFR)
AF:
AC:
18
AN:
152
American (AMR)
AF:
AC:
9
AN:
800
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
170
East Asian (EAS)
AF:
AC:
0
AN:
282
South Asian (SAS)
AF:
AC:
23
AN:
288
European-Finnish (FIN)
AF:
AC:
2
AN:
204
Middle Eastern (MID)
AF:
AC:
3
AN:
30
European-Non Finnish (NFE)
AF:
AC:
57
AN:
4974
Other (OTH)
AF:
AC:
7
AN:
370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0386 AC: 5883AN: 152314Hom.: 242 Cov.: 32 AF XY: 0.0382 AC XY: 2849AN XY: 74490 show subpopulations
GnomAD4 genome
AF:
AC:
5883
AN:
152314
Hom.:
Cov.:
32
AF XY:
AC XY:
2849
AN XY:
74490
show subpopulations
African (AFR)
AF:
AC:
4120
AN:
41554
American (AMR)
AF:
AC:
374
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
79
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
335
AN:
4828
European-Finnish (FIN)
AF:
AC:
78
AN:
10626
Middle Eastern (MID)
AF:
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
AC:
818
AN:
68032
Other (OTH)
AF:
AC:
68
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
264
527
791
1054
1318
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
111
AN:
3478
ClinVar
Significance: association
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Pulmonary disease, chronic obstructive, susceptibility to Other:1
Jul 05, 2022
HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas
Significance:association
Review Status:no assertion criteria provided
Collection Method:research
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.